Stockscreener 앱 받기
30.70
6.34%
-2.18
전일 마감가:
$32.88
열려 있는:
$30
하루 거래량:
1.15M
Relative Volume:
1.32
시가총액:
$1.90B
수익:
$13.05M
순이익/손실:
$-60.54M
주가수익비율:
-26.47
EPS:
-1.16
순현금흐름:
$-37.82M
1주 성능:
-4.45%
1개월 성능:
+19.50%
6개월 성능:
-44.29%
1년 성능:
-52.46%
1일 변동 폭
$29.23
$31.39
1주일 범위
$29.23
$33.97
52주 변동 폭
$22.52
$71.71
Janux Therapeutics Inc Stock (JANX) Company Profile
명칭
Janux Therapeutics Inc
전화
(858) 751-4493
주소
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
JANX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
JANX
Janux Therapeutics Inc
|
30.76 | 1.90B | 13.05M | -60.54M | -37.82M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.76 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
606.47 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
655.08 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.10 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.95 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-12-03 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-22 | 개시 | Leerink Partners | Outperform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-09-06 | 개시 | Stifel | Buy |
| 2024-05-30 | 개시 | Scotiabank | Sector Perform |
| 2024-03-21 | 개시 | BTIG Research | Buy |
| 2024-03-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-06 | 개시 | Wedbush | Outperform |
| 2022-11-14 | 개시 | William Blair | Outperform |
모두보기
Janux Therapeutics Inc 주식(JANX)의 최신 뉴스
Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross’ Stock Picks with Huge Upside Potential - Yahoo Finance
Janux Therapeutics begins phase 1b trial for prostate cancer therapy By Investing.com - Investing.com India
Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates - Business Wire
Is Janux Therapeutics, Inc. (JANX) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey
Unknown Billionaire Phill Gross’ 10 Stock Picks with Huge Upside Potential - Insider Monkey
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential - Insider Monkey
A new trading data show Janux Therapeutics Inc (JANX) is showing positive returns. - Sete News
Learn to Evaluate (JANX) using the Charts - news.stocktradersdaily.com
Trading Day Review: Janux Therapeutics Inc (JANX) Loses Momentum, Closing at 32.05 - DWinneX
Should Janux Therapeutics Inc (NASDAQ: JANX) Rally After -123.74% Drop From High? - Marketing Sentinel
Wells Fargo & Company MN Grows Stake in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Are Janux Therapeutics Inc’shares a good deal? - uspostnews.com
Latest Insider moments: Meyer Andrew Hollman, Janux Therapeutics Inc [JANX] Chief Business Officer sold 3,334 shares – Knox Daily - knoxdaily.com
Russell Investments Group Ltd. Buys 442 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Janux Therapeutics Inc (JANX) Worth Considering For The Next Few Weeks - Stocksregister
Legal & General Group Plc Boosts Stake in Janux Therapeutics, Inc. (NASDAQ:JANX) - American Banking and Market News
LPL Financial LLC Makes New $439,000 Investment in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Financial Metrics Exploration: Understanding Heron Therapeutics Inc (HRTX) Through Ratios - DWinneX
Cerity Partners LLC Acquires Shares of 4,478 Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Consensus Rating of “Buy” from Analysts - Defense World
Astera Labs, Inc. (NASDAQ:ALAB) Given Average Recommendation of “Buy” by Analysts - Defense World
Janux Therapeutics Inc (JANX)’s stock chart: A technical perspective - uspostnews.com
Janux Therapeutics Inc [JANX] Shares Rise 5.36 % on Wednesday - knoxdaily.com
Oncology’s Most Eligible Unpartnered Assets - insights.citeline.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Invesco Ltd. - Defense World
Long Term Trading Analysis for (JANX) - news.stocktradersdaily.com
Geode Capital Management LLC Boosts Stock Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
JPMorgan Chase & Co. Boosts Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
9,378 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Acquired by Sei Investments Co. - Defense World
Janux Therapeutics Inc (JANX)’s stock price in review: A technical analysis - uspostnews.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Vanguard Group Inc. - Defense World
Janux Therapeutics stock hits 52-week low at $23.72 By Investing.com - Investing.com South Africa
Janux Therapeutics stock hits 52-week low at $23.72 - Investing.com Australia
Janux Therapeutics: What's My Inflection Point? (NASDAQ:JANX) - Seeking Alpha
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Sold by Corebridge Financial Inc. - Defense World
Janux Therapeutics: Buying For The Promising Pipeline, Holding For The Buyout (NASDAQ:JANX) - Seeking Alpha
(JANX) Investment Report - news.stocktradersdaily.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Teacher Retirement System of Texas - Defense World
Janux Therapeutics stock hits 52-week low at $28.92 By Investing.com - Investing.com South Africa
Janux Therapeutics stock hits 52-week low at $28.92 - Investing.com India
Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts? - Insider Monkey
Is Janux Therapeutics, Inc. (NASDAQ:JANX) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey
Janux Therapeutics, Inc. (JANX): Among Stocks Receiving the Most Insider Love in March - MSN
We're Interested To See How Janux Therapeutics (NASDAQ:JANX) Uses Its Cash Hoard To Grow - Yahoo Finance
12 Best Up and Coming Stocks to Buy According to Wall Street Analysts - Insider Monkey
First Week of JANX November 21st Options Trading - Nasdaq
RA Capital Management, L.P. Increases Stake in Janux Therapeutics Inc - GuruFocus.com
Charles Schwab Investment Management Inc. Increases Stock Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
Insiders Are Spending Big: 15 Stocks Leading in March - Insider Monkey
Is Janux Therapeutics (JANX) a Worst High-Risk High-Reward Growth Stock to Buy? - Insider Monkey
Janux Therapeutics Inc (JANX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.30%
자본화:
|
볼륨(24시간):